Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals IncfiledCriticalIsis Pharmaceuticals Inc
Priority claimed from PCT/US2012/031642external-prioritypatent/WO2012135736A2/en
Publication of CU20130127A7publicationCriticalpatent/CU20130127A7/es
Publication of CU24088B1publicationCriticalpatent/CU24088B1/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Se describen en la presente compuestos antisentido y métodos para disminuir la expresión de ARNm y proteínas STAT3. Dichos métodos, compuestos y composiciones son de utilidad para tratar, prevenir o aliviar enfermedades hiperproliferativas.
CU2013000127A2011-04-012012-03-30Oligonucleótido de cadena simple inhibidor de la proteína stat3
CU24088B1
(es)